Login
Israel-Hamas Conflict
Protestors
Donald Trump
World Cup
Military
Boxing
Social Media
Soccer
Baseball
Cricket
Cryptocurrency
Infrastructure
Immigration
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

healtheconomics.com image

News from healtheconomics.com

Information about healtheconomics.com

Where is healtheconomics.com located?healtheconomics.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top healtheconomics.com News

FDA Rushed Out Agency-Wide AI Tool—It’s Not Going Well
FDA · United States

FDA Rushed Out Agency-Wide AI Tool—It’s Not Going Well

50% Center coverage: 10 sources
An agency-wide LLM called Elsa was released weeks ahead of schedule.See the Story
Early Camizestrant Therapy Keeps Advanced Breast Cancer in Check
Breast Cancer

Early Camizestrant Therapy Keeps Advanced Breast Cancer in Check

67% Center coverage: 3 sources
Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains quality of life in patients with ESR1-mutated, hormone receptor-positive advanced breast cancer. The proactive, biomarker-guided approach allows earlier intervention and may redefine standard care.See the Story
Pregnancy: No Reason Not to Treat Migraine
European Parliament

Pregnancy: No Reason Not to Treat Migraine

100% Right coverage: 1 sources
Sumatriptan and onabotulinumtoxinA are safe options during pregnancy.See the Story

Three-Year Data Reveals Long-Term Power of Bimekizumab for PsA

At the 2025 EULAR meeting, UCB presented new 3-year data on bimekizumab for PsA.See the Story

Leveraging Statistical Data Monitoring to Detect Fraud in Clinical Trials

Ensuring data integrity in clinical trials is crucial, as emphasized by the International Council for Harmonization’s E6 (R3) guidelines. This article delves into the role of statistical data monitoring in identifying potential data manipulation, highlighting the effectiveness of various statistical tests for continuous variables in detecting deliberate data falsification. Fraud in clinical trials often involves subtle manipulations to avoid det…Read Article

INsights & OUTcomes with Matt McLoughlin

This episode features Matt McLoughlin, Senior Vice President of Compliance and Categories at Scientist.com. With 25 years in pharma R&D and Procurement, Matt has enhanced outsourcing for biopharma companies, focusing on speed, efficiency, and compliance. His expertise in regulated industries extends to RWE, HEOR, and Market Access, transforming access to external services to boost innovation while cutting costs and project timelines. Watch the i…Read Article

5 Key Questions to Ask Before You Launch a Value Evidence Plan

Written by: Hayleigh Culliton, HealthEconomics.com As expectations mount for stakeholders to demonstrate value, for teams working in HEOR, RWE, and Market Access a common challenge is emerging: how can you proactively plan for future projects without duplicating efforts, creating gaps in the data, or starting too late? After attending ISPOR 2025, there was a clear call to action: in order to build a fully integrated, cross-functional evidence pl…Read Article

Pharma sector sees $6.96 billion in global deal activity in May 2025, led by GSK, Shionogi, and Eli Lilly: GlobalData - Express Pharma

According to the GlobalData report, the global pharma industry reported 76 mergers and acquisitions (M&A) deals in May 2025, amounting to a total disclosed value of $6.96 billion. This figure marks a decline compared to the previous 12-month average from May 2024 to April 2025, which recorded 95 deals worth $12.4 billion. According to industry data, three major transactions contributed 59 per cent of the total deal value in May. GSK announced it…Eli LillySee the Story

Challenges and Opportunities in Advancing Gene Therapy: Insights from FDA Roundtable

The story of KJ Muldoon, a 10-month-old infant whose life-threatening CSP1 deficiency was stabilized through a custom CRISPR therapy, highlights the transformative potential of genetic medicine. This personalized treatment allowed KJ to resume a normal diet without requiring a liver transplant, exemplifying the promise of genetic therapies to treat rare diseases. Despite such successes, the gene therapy field faces significant challenges, as dis…United States · United StatesRead Article

Bayer drug could ease side effects of common breast cancer treatment, detailed data show

100% Center coverage: 1 sources
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.Breast CancerSee the Story

Trump's Executive Order on Reducing Prescription Drug Prices Will Have Limited Impact on Indian Pharma Companies: Crisil Ratings

100% Right coverage: 1 sources
Get latest articles and stories on Business at LatestLY. Citing the reason behind its observation, the credit rating firm in its report said that despite India exporting over half of its pharmaceutical output, the bulk comprises low-priced generic drugs, which already operate on razor-thin margins, leaving little room for further price cuts to materially affect revenues. Business News | Trump's Executive Order on Reducing Prescription Drug Price…Donald Trump · IndiaSee the Story

Breaking News Topics Related to healtheconomics.com

Health

Health

Medical

Medical

United States

United States

News
For You
SearchBlindspotLocal